Astra and Sanofi’s RSV jab takes a step towards market
A pivotal win puts nirsevimab on track to be filed next year, but the reimbursement hurdle looms.
Valneva joins the phase 3 Covid-19 vaccine club
Meanwhile, Ocugen hopes that Covaxin's India data will be enough for US approval.
Europe needs to be clearer about Covid-19 vaccines
Confusion over blood clot numbers with all four approved Covid-19 vaccines could cause more vaccine hesitancy.
Astra and Sanofi’s RSV jab takes a step towards market
A pivotal win puts nirsevimab on track to be filed next year, but the reimbursement hurdle looms.
Valneva joins the phase 3 Covid-19 vaccine club
Meanwhile, Ocugen hopes that Covaxin's India data will be enough for US approval.
Europe needs to be clearer about Covid-19 vaccines
Confusion over blood clot numbers with all four approved Covid-19 vaccines could cause more vaccine hesitancy.
